{"id":101,"date":"2013-08-01T14:24:51","date_gmt":"2013-08-01T14:24:51","guid":{"rendered":"http:\/\/jacobimed.org\/NS\/?page_id=101"},"modified":"2016-08-04T13:36:13","modified_gmt":"2016-08-04T13:36:13","slug":"research","status":"publish","type":"page","link":"https:\/\/jacobimed.org\/old\/nephrology-fellowshipoverview\/research\/","title":{"rendered":"Research"},"content":{"rendered":"<div>\n<p>The Jacobi Department of Medicine\u2019s close affiliation with the Albert Einstein College of Medicine affords many opportunities for research. Clinical or laboratory research projects are generally undertaken during elective time in the second year of fellowship. In addition our fellows are provided opportunities for research at Columbia Presbyterian Hospital.<\/p>\n<p>Our fellows have been able to perform high quality research with nationally and internationally recognized experts in Nephrology.<\/p>\n<p>All our fellows have presented their work at the national meetings such as the American Society of Nephrology and the National Kidney Foundation. In addition, our fellows have authored papers in top ranking scientific journals. They have been winners at the \u201cFellows\u2019 Night \u201d held at Cornell University Medical Center by the New York Society of Nephrology.<\/p>\n<p>On the Jacobi campus, the new Price Center for Translational and Molecular Biology Research is evidence of Einstein\u2019s continuing commitment to excellence in Medical Research.<\/p>\n<p>&nbsp;<\/p>\n<p>Investigator-initiated Research topics include:<\/p>\n<ul>\n<li>Improving care of the patient with chronic kidney disease (CKD)<\/li>\n<li>Improving care of the new dialysis patient<\/li>\n<li>Vitamin D and sepsis<\/li>\n<li>Epidemiology of Acute Kidney Injury (AKI)<\/li>\n<li>Preeclampsia<\/li>\n<li>Urinary biomarkers in diabetic renal disease<\/li>\n<li>Urinary biomarkers in hepatorenal disease<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Landmark mutlicenter trials include:<\/p>\n<ul>\n<li>Trial to Reduce Cardiovascular Events with Aranesp Therapy-TREAT Trial using darbepoetin alpha in CKD patients<\/li>\n<li>Registry of patients with secondary hyperparathyroidism in Chronic Kidney Disease<\/li>\n<li>A multicentre, randomized, double-blind, parallelgroup, phase IV study to compare the renal effects of a non-ionic iso-osmolar contrast medium iodixanol 320 mgl\/ml(VisipaqueTM) with a non-ionic low osmolar contrast medium iopamidol 370 mgl\/ml)<\/li>\n<li>Pharmacoeconomic Evaluation (Time and Motion) Comparing RO0503821 to Epoetin Alfa in Patients with Chronic Kidney Disease (CKD) Stage V On Dialysis<\/li>\n<li>A randomized, single blind trial to assess the effectiveness of maintaining patency and safety of the vascular wrap\u2122 Paclitaxel-eluting mesh after surgical implantation with the Lifespan\u00ae PTFE vascular graft in the upper extremity for hemodialysis vascular access<\/li>\n<li>A phase IIIb, randomized, double-blind, parallel group, multi-center, study to assess the efficacy and safety of multiple 30 minute infusions of Conivaptan in subjects with euvolemic or hypervolemic hyponatremia.<\/li>\n<li>A multi center study using Lanthanum Carbonate as treatment for hyperparathyroidism in E.S.R.D patients \u2013 F.E.A.T.U.R.E Trial<\/li>\n<li>A phase 3, Randomized controlled, Open label, multi center Study of the safety and efficacy of AF37702 Injection for the maintenance treatment of anemia in hemodialysis patients previously treated with Epoetin alfa<\/li>\n<li>An Observer-Blinded, Randomized Study Comparing the Safety and Immunogenicity of HEPLISAVTM to Licensed Vaccine (Energix-B\u00ae) among Adults (18-70 Years of Age) with Chronic Kidney Disease (CKD)<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Ongoing Clinical Trials:<\/p>\n<ul>\n<li>Dialysis Registry<\/li>\n<li>Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes<\/li>\n<li>DPP4 inhibitor in DM\/CKD<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<\/div>\n<h4>A. Original Communications in Reviewed Journals:<\/h4>\n<p>Glicklich D, Acharya A; \u201cMycophenolate Mofetil Therapy for Lupus Nephritis Refractory to Intravenous Cyclophosphamide\u201d, Am J Kidney Dis. 1998 Aug; 32(2):318-22<\/p>\n<p>Neugarten J, Acharya A, Silbiger SR.; \u201cSelective Effects of Gender on the progression of Non-diabetic renal disease: a meta-analysis\u201d, J Am Soc Nephrol. 2000 Feb; 11(2):319-29<\/p>\n<p>Neugarten J, Acharya A, Lei J, Silbiger S.; \u201cSelective Estrogen Recepetor Modulators Suppress Mesangial Cell Collagen Synthesis\u201d, American Journal of Physiology, 2000 Aug; 279(2):F309-18<\/p>\n<p>Zaidi M, Singh N, Kamran M, Ansari N, Nasr SH, Acharya A; Acute onset of hematuria and proteinuria associated with multiorgan involvement of the heart, liver, pancreas, kidneys, and skin in a patient with Henoch-Sch\u00f6nlein purpura, Kidney Int. 2008 Feb; 73(4):503-8. Epub 2007 Nov 21<\/p>\n<p>Zaidi M, Singh N, Kamran M, Ansari N, Nasr SH, Acharya A; Letter to the Editor entitled Response to Multiorgan involvement of vasculitis: Henoch-Sch\u00f6nlein purpura alone or polyangiitis overlap syndrome?, Kidney International 74, 828-829 (29 August 2008) doi:10.1038\/ki.2008.278 Letter to the Editor<\/p>\n<p>Coritsidis G, Sutariya D, Stern A, Gupta G, Stafford J, Arora R, Balmir S and Acharya A; Does timing of dialysis in ESRD patients with acute myocardial infarcts affect morbidity or mortality? Clin J Am Soc Nephrol. 2009 Aug; 4(8):1324-30<\/p>\n<p>Belinda Jim, Pascale Jean-Louis, Andi Qipo,David Garry,Samia Mian, Tulio Matos, Christopher Provenzano, and Anjali Acharya ; Podocyturia as a Diagnostic Marker for Preeclampsia amongst High-Risk Pregnant Patients, Journal of Pregnancy.Volume 2012 (2012), Article ID 984630, 5 pages, doi:10.1155\/2012\/984630<\/p>\n<h4>B. Invited Review:<\/h4>\n<p>Jim B, Sharma S, Kebede T, Acharya A. Cardiology in Review: Pregnancy induced proteinuria and Hypertension -A review: Cardiology in Review Aug 2010<\/p>\n<p>Acharya A, Jim B. The critically ill patient with chronic kidney disease. In: John Kellum. Renal and Metabolic Disorders, Oxford University Press, 29-38, 2013<\/p>\n<p>Anjali Acharya , Jolina Santos, Brian Linde and Kisra Anis,; Acute Kidney Injury in Pregnancy\u2014Current Status, Advances in Chronic Kidney Disease, Volume 20, Issue 3 , Pages 215-222, May 2013<\/p>\n<h4>C. Posters and Abstracts:<\/h4>\n<p>&nbsp;<\/p>\n<h5>2001<\/h5>\n<p>Naheed Ansari, Serban Fotino, Anjali Acharya; Secondary Amyloidosis of the kidneys can cause ESRD after 27 years of initial diagnosis ASN 34th Annual Renal Week Meeting.<\/p>\n<h5>2001<\/h5>\n<p>Anjali Acharya, Naheed Ansari, Serban Fotino; Nephrotic Syndrome and stroke in a patient with Salmonella Enteriditis bacteremia ASN 34th Annual Renal Week Meeting.<\/p>\n<h5>2002<\/h5>\n<p>Valentin Zaharia, Naheed Ansari, Sorin Beca, Anjali Acharya; Elevation of Pancreatic Enzymes in Acute Renal Failure JASN<br \/>\n(Pub 097)<\/p>\n<h5>2002<\/h5>\n<p>Naheed Ansari, Anjali Acharya; A strange case of pyelonephritis without pyuria and rapidly progressive renal failure JASN (Pub 040)<\/p>\n<h5>2003<\/h5>\n<p>Anjali Acharya, Serban Fotino, Naheed Ansari, Kisra Anis; Second episode of necrotizing P ANCA associated RPGN presenting 20 years after complete remission of first episode of RPGN in a patient with Systemic Sclerosis JASN (Pub 123)<\/p>\n<h5>2003<\/h5>\n<p>Naheed Ansari, Anjali Acharya, Kisra Anis, Valentin Zaharia; Hepatitis B associated MPGN with crescents and rapid progression to ESRD JASN (Pub 117)<\/p>\n<h5>2006<\/h5>\n<p>George N Coritsidis, Aaron Stern, Anwar Khan, Sutariya, Anjali Acharya, Robin Arora, Serge Balmir, Stafford John and Garima Gupta; Does timing of dialysis in ESRD patients with acute myocardial infarcts affect morbidity or mortality?<br \/>\nASN 39th Annual Renal Week Meeting.<\/p>\n<h5>2007<\/h5>\n<p>Susan Hailpern, Robin Arora, Salman Waheed, Anjali Acharya; Clinical predictors of severity of proteinuria in a cohort of patients with Hepatitis C and proteinuria NKF Meetings<\/p>\n<h5>2007<\/h5>\n<p>Nandita Singh, Naheed Ansari, Anjali Acharya; Severe hypokalemia and thyroid storm secondary to iodinated contrast NKF Meetings<\/p>\n<h5>2007<\/h5>\n<p>Jim B, Singh N, Ansari N, Anis K, Mundel P, Akai Y, Acharya A. Podocyte Injury Occurs in the Course of Preeclampsia, National Kidney Foundation Spring Clinical Meetings<\/p>\n<h5>2007<\/h5>\n<p>Jim B, Singh N, Kim K, Ansari N, Anis K, Mundel P, Acharya A. sFlt-Fc Upregulates Synaptopodin Expression in Podocytes, National Kidney Foundation Spring Clinical Meetings<\/p>\n<h5>2007<\/h5>\n<p>Belinda Jim, Nandita Singh, Kwanghee Kim, Naheed Ansari, Kisra Anis, Peter Mundel, Anjali Acharya; sFlt-Fc Upregulates Synaptopodin Expression in Podocytes ASN 40th Annual Renal Week Meeting<\/p>\n<h5>2008<\/h5>\n<p>Christopher Provenzano, Anjali Acharya; A case of metformin-associated lactic acidosis (MALA) in a chronic dialysis patient NKF Meetings<\/p>\n<h5>2008<\/h5>\n<p>Muhammad Mustafa, Anjali Acharya; Interstitial nephritis as the only renal lesion with C-ANCA positive Wegener\u2019s disease &#8211; an unusual renal presentation; NKF Meetings<\/p>\n<h5>2008<\/h5>\n<p>Christopher R. Provenzano, Anjali Acharya; Acute proliferative glomerulonephritis as the result of catastrophic anti phospholipid syndrome (CAPS) NKF Meetings<\/p>\n<h5>2008<\/h5>\n<p>Mythili Ghanta, Sriranga L Bonam, Rajan Kapoor, Anjali Acharya; Venous thromboembolism as the initial presentation of primary renal amyloidosis NKF Meetings<\/p>\n<h5>2008<\/h5>\n<p>Coritsidis G, Mayne TJ, Acharya A, Gitlin M, Gnanasekaran A, Stanescu C, Bonam S, Ganta M, Anis K, Thompson N, Joseph N, Dungca C, Shahata H, Tannenberg A, Gupta G, Pogue V, Gilbertson D, Collins A., and the HHC Dialysis Research Group (DRG); Dialysis Care in New York City: The Intersection of National and Local Data: ASN 41st Annual Renal Week Meeting.<\/p>\n<h5>2008<\/h5>\n<p>Belinda Jim, Tulio Matos, David Garry, Anjali Acharya, Mian Samia, Mireia Castillo, Christopher Provenzano, Pascale Jean-Louis; Urinary Podocyte Excretion as a Marker for Preeclampsia and Other High Risk Pregnancy States: ASN 41st Annual Renal Week Meeting.<\/p>\n<h5>2008<\/h5>\n<p>Jim B, Matos T, Garry D, Acharya A, Mian S, Castillo M, Jean-Louis P, Urinary Podocyte Excretion as a Marker for Preeclampsia and Other High Risk Pregnancy States, American Society of Nephrology, 2008<\/p>\n<h5>2008<\/h5>\n<p>Sri Ranga Bonam, Mythili Ghanta, Mekdess Abebe, Christopher Provenzano, Anjali Acharya; CMV Infection of the Hypothalamus Causing Central Diabetes Insipidus JASN (Pub 023)<\/p>\n<h5>2008<\/h5>\n<p>George N. Coritsidis, Anjali Acharya, Isaiarasi Gnanasekaran, Catherine Stanescu, Garima Gupta, Sri Bonam, Hani Shahata, Nathan Thompson, Mary Mallappallil, Nathan Joseph, Alf Tannenberg, Jen-Tse Cheng, Consuelo Dungca, Ganta Mythili; Health and Hospitals Corporation of New York City (HHC) Outcome Data: Population Variability Compared to the USRDS Population May Explain Outcome Differences JASN (Pub 388)<\/p>\n<h5>2009<\/h5>\n<p>Acharya A, Stanescu C , Bonam S, Puram A, Zelkowitz M, Anis K , Gupta G, Mihaltses J, Coritsidis G; Baseline Demographic and Biochemical Characteristics of Dialysis Population in Two New York City\u2019s Health and Hospital Corporation (HHC) Hospitals Compared with the USRDS Population: NKF Meetings.<\/p>\n<h5>2009<\/h5>\n<p>Marc Zelkowitz, Sri Bonam, Nandita Singh, Salman Waheed, Ashok Talreja, Flavio Rivera, Ofer Sagiv, Jay Gross, Hillel Cohen and Anjali Acharya; CKD and Incidence of Arrhythmias in Patients with Internal Cardiac Defibrillators: NKF Meetings<\/p>\n<h5>2009<\/h5>\n<p>Mallappallil M, Acharya A, , Coritsidis G, Gitlin M, Gnanasekaran I, Naheed Ansari, Pogue V, Thompson N, Shahata H, Tannenberg A, Vijay Nandi, David Vlahov, and Mayne TJ, Catheter time can be long in large urban public health hospitals. Accepted for presentation at ASN<\/p>\n<h5>2009<\/h5>\n<p>Acharya A, , Coritsidis G, Gitlin M, Gnanasekaran I, Idalia Alaniz, Pogue V, Thompson N, Mallappallil M, Shahata H, Pogue V, Tannenberg A, Mathew Thomas, Vijay Nandi , David Vlahov, Mathew Gitlin , and Mayne TJ, New York Public Health Hospitals Have High Levels Of Uninsured Patients, Predicting Poor Pre-Dialysis Care: Accepted for presentation at ASN<\/p>\n<h5>2010<\/h5>\n<p>Shuchita Sharma, Marc Zelkowitz, Ganesh Kambhampati, Sri L. Bonam, Jay Gross, Hillel W. Cohen, Anjali Acharya Nephrology, Jacobi Medical Center, Bronx, NY; Biostatistics, Albert Einstein College of Medicine, Bronx, NY; Cardiology, Montefiore Medical Center, Bronx, NY; Ejection Fraction, Kidney Function and Arrythmias in Patients with Automatic Internal Cardiac Defibrillators<\/p>\n<h5>2010<\/h5>\n<p>Zaher Hamadeh, Pu Zong, Manish Ramesh, Anjali Acharya. Department of Nephrology, Albert Einstein College of Medicine (Jacobi), Bronx, NY Assessing and Tracking Impact of Use of Sodium Polystyrene Sulfonate in an Inner City Hospital<\/p>\n<h5>2010<\/h5>\n<p>Praneetha Puskuri, Zaher Hamadeh, Anjali Acharya, Jacobi Medical Center, Division of Nephrology, Albert Einstein College of Medicine, Bronx, NY, USA Bulimia as a Cause of Metbolic Alkalosis in a Patient with Chronic Kidney<br \/>\nDisease<\/p>\n<h5>2010<\/h5>\n<p>Egbosimba, Florence C. Rutgers University, NJ, Hannah Nelson, Praneetha Puskuri, Anjali Acharya, Jacobi Medical Center, Bronx, NY, USA Cost Assessment of Patients with Excessive Hospital Stays in an Inner City Hospital<\/p>\n<h5>2010<\/h5>\n<p>Tewabe Kebede, Mohan Pamerla, Shuchita Sharma, Anjali Acharya; Jacobi Medical Center\/ Albert Einstein College of Medicine; Division of Nephrology; Bronx, NY, USA Intradialytic Use of Heparin: Is Heparin Necessary for Stable Chronic Hemodialysis Treatments?<\/p>\n<h5>2010<\/h5>\n<p>George N. Coritsidis, Anjali Acharya, Ross Miller, Kelly J. Ko, Akhtar Ashfaq, Irene Agodoa. NYC Health and Hospitals Corporation, New York, NY; Cerner LifeSciences, Beverly Hills, CA; Amgen Inc, Thousand Oaks, CA End-Stage Renal Disease (ESRD) Prospective Payment System (PPS): Identifying and Assessing Impact on Hospital-Based Dialysis Centers (HBDCs) ASN<\/p>\n<h5>2011<\/h5>\n<p>Zaher Hamadeh, Pu Zong, Manish Ramesh and Anjali Acharya, Assessing and Tracking Impact of Use of Sodium Polystyrene Sulfonate in an Inner City Hospital. ASN<\/p>\n<h5>2011<\/h5>\n<p>Anjali Acharya, Sophie Kwok, Venu Gopal Kankani, Rakesh Malhotra. A Comparison between Patients Referred and Not Referred to an Inner:city Nephrology Clinics, ASN<\/p>\n<h5>2011<\/h5>\n<p>Josee Bouchard, Anjali Acharya, Jorge Cerda, Elizabeth R. Maccariello, Rajasekara Chakravarthi Madarasu, Ashita J. Tolwani, Xinling Liang, Ping Fu, Zhi-Hong Liu,Ravindra L. Mehta. Epidemiology of Acute Kidney Injury from the O\u2019Brien Center Registry, ASN<\/p>\n<h5>2011<\/h5>\n<p>Josee Bouchard, Anjali Acharya, Jorge Cerda, Elizabeth R. Maccariello, Rajasekara Chakravarthi Madarasu, Ashita J. Tolwani, Xinling Liang, Ping Fu, Zhi-Hong Liu,Ravindra L. Mehta.Risk Factors and Etiology of Acute Kidney Injury in Intensive Care Unit Patients: the Multicenter International O&#8217;Brien Center Registry, ASN<\/p>\n<h5>2011<\/h5>\n<p>Etienne Macedo, Josee Bouchard, Jorge Cerda, Ashita J. Tolwani, Anjali Acharya, Gary R. Cutter, Ravindra L. Mehta.<br \/>\nFactors Associated with the Decision Making Process in Dialysis Initiation<br \/>\nin AKI: Results of a Survey<\/p>\n<h5>2011<\/h5>\n<p>George N. Coritsidis, Gregory A. Maglinte, Chun-Lan Chang, Anjali Acharya, Nathan Thompson, Jerrold W. Hill, Ze Cong, Akhtar Ashfaq, Jeffrey Petersen. Assessment of Quality Incentive Program (QIP) Preparedness in Hospital-Based Dialysis Centers (HBDCs) and Independent Dialysis Organizations (IDOs) in 2010<\/p>\n<h5>2011<\/h5>\n<p>Etienne Macedo, Josee Bouchard, Jorge Cerda, Ashita J. Tolwani, Anjali Acharya, Gary R. Cutter, Ravindra L. Mehta. Can Objective Criteria Improve Decisions for Dialysis Initiation in AKI?<\/p>\n<h5>2011<\/h5>\n<p>Josee Bouchard, Jiandong Wei, Sharon Soroko, Anjali Acharya, Jorge Cerda, Elizabeth R.Maccariello, Rajasekara Chakravarthi Madarasu, Ashita J. Tolwani, Xinling Liang, Ping Fu, Zhi-Hong Liu, Ravindra L. Mehta. Natural History of Acute Kidney Injury in Intensive Care Unit Patients: The Multicenter International O\u2019Brien Center Registry. ASN<\/p>\n<h5>2012<\/h5>\n<p>Mehta S, Qipo A, Sharma S, Acharya A, Jim B. Urinary Albumin vs. Urinary Nephrin in Predicting the Development of Preeclampsia, National Kidney Foundation Spring Clinical Meetings<\/p>\n<h5>2012<\/h5>\n<p>Ajith Kumar Puram, Amit Kumar Misra, Andi Qipo, Stuart M. Greenstein, Amit Shah, Erian Shehu, Anjali Acharya. Comparison of Vein Size on Maturation of Radiocephalic AVF, NKF<\/p>\n<h5>2012<\/h5>\n<p>Srujana Polsani, Rakesh Malhotra, Erian Shehu, Anjali Acharya. Effects of Tenofovir on CKD Progression<\/p>\n<h3>Bibliography<\/h3>\n<h4>Original Communications in Reviewed Journals:<\/h4>\n<p>Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN. Reversibility of established diabetic glomerulopathy by anti-TGF-\uf062 antibodies in db\/db mice. Biochem Biophys Res Commun. 300:16-22, 2003<\/p>\n<p>Chen S, Jim B, Ziyadeh FN. Diabetic nephropathy and transforming growth factor- \u03b2: Transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol. 3:532-543, 2003<\/p>\n<p>Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, Kopp JB, Ziyadeh FN. Cultured tubule cells from TGF- \u03b2 1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Kidney International. 65:1191-204, 2004<\/p>\n<p>Chen S, Kasama Y, Lee J, Jim B, Marin M, Ziyadeh FN. Podocyte-derived Vascular Endothelial Growth Factor Mediates the Stimulation of \uf0613(IV) Collagen Production by Transforming Growth Factor- \u03b2 1 in Mouse Podocytes. Diabetes. 53:2939-2949, 2004<\/p>\n<p>Brukamp K, Jim B, Moeller MJ, Haase VH. Hypoxia and Podocyte-specific Vhlh deletion confer risk of glomerular disease. Am J Physiol Renal Physiol. 293:F1397-407, 2007<\/p>\n<p>Chuang PY, Dai Y, Liu R, He H, Kretzler M, Jim B, Cohen CD, He JC. Alteration of forkhead box o (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One. 6(8):e23566, 2011.<\/p>\n<p>Kwok S, Agati VD, Anis K, Jim B. An unusual case of nephrotic syndrome and glucosuria Am J Kid Disease. 59:734-737, 2012<\/p>\n<p>Jim B. Jean-Louis P, Qipo A, Garry G, Mian S, Matos T, Provenzano C, Acharya A Podocyturia as a diagnostic marker for preeclampsia amongst high risk pregnant patients Journal of Pregnancy. Article ID 984630, 2012<\/p>\n<p>Jim B, Ghanta M, Qipo A, Ying F, Chuang PY, Cohen HW, Abadi M, Thomas DB, He JC. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: A cross sectional study. PLoS One. 7(5):e36041. doi:10.1371\/journal.pone.0036041, 2012<\/p>\n<h4>Books, Chapters in Books, and Review Articles:<\/h4>\n<p>Jim B. \u201cBook Review: War and Public Health\u201d by Barry S. Levy, Victor W. Sidel, Einstein Quart J Biol Med.14:165-166, 1997<\/p>\n<p>Jim B, Chen S, Ziyadeh FN. Transforming growth factor-\u03b2 and other cytokines in experimental and human diabetic nephropathy. In: Carl Erik Mogensen. The Kidney and Hypertension in Diabetes Mellitus, 6th edition. United Kingdom: Taylor &amp; Francis Group, 397-432, 2004<\/p>\n<p>Jim B, Sharma S, Kebede T, Acharya A. Hypertension in Pregnancy: a Comprehensive Update. Cardiology in Review. 18:178-189, 2010<\/p>\n<p>Jim B, Santos J, Spath F, He JC. Biomarkers of Diabetic Nephropathy, the Present and the Future. Current Diabetes Review. 7:317-328, 2012<\/p>\n<p>Acharya A, Jim B. The critically ill patient with chronic kidney disease. In: John Kellum. Renal and Metabolic Disorders, Oxford University Press, 29-38, 2013<\/p>\n<p>Polsani S, Phipps E, Jim, B. Emerging Biomarkers of Preeclampsia. Advances in Chronic Kidney Diseases. 20:271-279, 2013.<\/p>\n<p>Jim B, Hou S. Pregnancy and Kidney Disease- the Miracle Continues Against All Odds, Advances in Chronic Kidney Diseases. 20:206-208, 2013<\/p>\n<p>Mehta S, Cabrera V, Upputalla R, Jim B. Urinary Biomarkers of Diabetic Nephropathy. Current Biomarker Findings, 2013, in press<\/p>\n<h4>Abstracts:<\/h4>\n<p>Jim B, Doyle A, Bloom R. Rapamycin is Associated with Worsening Proteinuria in Transplant Patients with Renal Injury: A Report of Four Cases, 2003<\/p>\n<p>Jim B, Biju M, Moeller M, Holzman L, Haase V. The Role of Hypoxia Inducible Factor in Podocyte Function and Disease, 2004<\/p>\n<p>Chen S, Kasama Y, Lee J, Jim B, Marin M, Ziyadeh FN. VEGF Stimulates the Production of Collagen IV by Mouse Podocytes in an Autocrine Loop, American Society of Nephrology 2003<\/p>\n<p>Akai Y, Biju M, Higgins D, Jim B, Wutz A, Johnson R, Haase V. HIF-1\uf061-Deficient Renal Tubular Cells are Protected from Hypoxia-Mediated Cell Death, American Society of Nephrology, 2003<\/p>\n<p>Brukamp K, Jim B, Moeller M, Holzman L, Haase V. VHL Deficiency in Novel Podocyte Cell Line Results in Survival Disadvantage, American Society of Nephrology, 2005<\/p>\n<p>Jim B, Singh N, Ansari N, Anis K, Mundel P, Akai Y, Acharya A. Podocyte Injury Occurs in the Course of Preeclampsia, National Kidney Foundation Spring Clinical Meetings, 2007<\/p>\n<p>Jim B, Singh N, Kim K, Ansari N, Anis K, Mundel P, Acharya A. sFlt-Fc Upregulates Synaptopodin Expression in Podocytes, National Kidney Foundation Spring Clinical Meetings, 2007<\/p>\n<p>Mian S, Jim B. Podocyturia in Preeclampsia and Patients at High Risk for Preeclampsia, National Kidney Foundation Spring Clinical Meetings, 2008<\/p>\n<p>Jim B, Matos T, Garry D, Acharya A, Mian S, Castillo M, Jean-Louis P, Urinary Podocyte Excretion as a Marker for Preeclampsia and Other High Risk Pregnancy States, American Society of Nephrology, 2008<\/p>\n<p>Ghanta M, Sharma S, Bonam, S, Cohen H, Matos T, Jim B. Expression Analysis of Podocyte-Specific Proteins in Diabetic Nephropathy, National Kidney Foundation Spring Clinical Meetings, 2009<\/p>\n<p>Sharma S, Bonal D, Thomas D, Jim B. Urinary Excretion of Podocytes as an Early Marker of Diabetic Nephropathy, National Kidney Foundation Spring Clinical Meetings, 2010<\/p>\n<p>Kebede T, Ghanta M, Sharma S, Abebe M, Cohen H, Puskuri P, Jim B. Decreased Podocyte-specific Protein Expression Correlates with Severity of Diabetic Nephropathy, National Kidney Foundation Spring Clinical Meetings, 2010<\/p>\n<p>Qipo A, Cohen, HW, Jim B. Urinary Nephrin as an Early Biomarker of Diabetic Nephropathy, National Kidney Foundation Spring Clinical Meetings, 2011<\/p>\n<p>Sharma S, Qipo A, Kim K, Zong P, Mehta S, Bonal D, Jim B. Nephrinuria vs. Podocyturia: Which Is a Better Early Marker for Diabetic Nephropathy?\u201d American Society of Nephrology, 2011<\/p>\n<p>Mehta S, Qipo A, Sharma S, Acharya A, Jim B. Urinary Albumin vs. Urinary Nephrin in Predicting the Development of Preeclampsia, National Kidney Foundation Spring Clinical Meetings, 2012<\/p>\n<p>Polsani S, Santos J, Anis K, Qipo A, Jim B. Caucasian Race as Risk Factor for Vancomycin Nephrotoxicity, American Society Nephrology, 2012<\/p>\n<p>Santos J, Polsani S, Jim B, Ansari N. De Novo Fibrillary Glomerulonephritis in a Renal Allograft of a Patient with Hepatitis C, National Kidney Foundation Spring Clinical Meetings, 2013<\/p>\n<p>Spath F, Jim B, Anis K. Retrospective Analysis of a Dialysis Population with Prevalent Psychiatric Conditions, National Kidney Foundation Spring Clinical Meetings, 2013<\/p>\n<p>Merzkani M, Jim B, Anis K. Frequent Relapse of Clostridum Difficile Infection Associated with End Stage Renal Disease, National Kidney Foundation Spring Clinical Meetings, 2013<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Jacobi Department of Medicine\u2019s close affiliation with the Albert Einstein College of Medicine affords many opportunities for research. Clinical or laboratory research projects are generally undertaken during elective time in the second year of fellowship. In addition our fellows are provided opportunities for research at Columbia Presbyterian Hospital. Our fellows have been able to&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":90,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"class_list":["post-101","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/comments?post=101"}],"version-history":[{"count":29,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/101\/revisions"}],"predecessor-version":[{"id":3450,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/101\/revisions\/3450"}],"up":[{"embeddable":true,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/90"}],"wp:attachment":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/media?parent=101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}